Reduction in inflammation in the footpad of carrageenan treated mice following the topical administration of anti-TNF molecules formulated in a micro-emulsion

Journal of Controlled Release

Volumn 145, Issue 3, 2010, Pages 210-213

  Himes, R ^a   Lee, S ^a   McMenigall, K ^a   Russell Jones, G J ^a  

^a Apollo Life Sciences   (Australia)

Author keywords

Anti TNF; Micro emulsion; Protein delivery; Topical; Transdermal

Indexed keywords

ANTI-TUMORS; CARRAGEENANS; DELIVERY SYSTEMS; DERMAL LAYERS; PHARMACEUTICAL AGENTS; PROTEIN DELIVERY; PROTEIN PHARMACEUTICALS; SOLUBLE PEPTIDES; TRANSDERMAL; WATER-IN-OIL;

EMULSIFICATION; MONOCLONAL ANTIBODIES; PEPTIDES; WATER INJECTION;

DRUG PRODUCTS;

ADALIMUMAB; CARRAGEENAN; ETANERCEPT; INFLIXIMAB; OIL; PROTEIN ALSTII; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; WATER; ANTIINFLAMMATORY AGENT; EMULSION; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; FEMALE; FOOT PAD; HYDROPHILICITY; INFLAMMATION; MICROEMULSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; ANIMAL; EMULSION; IMMUNOLOGY; METABOLISM; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CARRAGEENAN; EMULSIONS; FEMALE; INFLAMMATION; MICE; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954312020     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.04.023     Document Type: Article

References (15)

1. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug. Del. Rev. 2002, 54:S77-S98.
2. Getie M., Wohlrab J., Neubert R.H.H. Dermal delivery of desmopressin actetate using colloidal carrier systems. J. Pharm. Pharmacol. 2005, 57:423-427.
3. Goebel A., Neubert R.H.H. Dermal peptide delivery using colloidal carrier systems. Skin Pharmacol. Physiol. 2008, 21:3-9.
4. Uren R.F., Howard-Giles R., Thompson J.F. Patterns of lymphatic drainage in the skin of patients with melanoma. J. Nucl. Med. 2003, 44:570-582.
5. G.J. Russell-Jones, S.R. Lee, K. McMenigall, M. Luke, R. Himes, Topical delivery of proteins using microemulsions, recent advances in drug delivery systems. Salt Lake City, Utah, Feb. 2007.
6. Greenwood F.C., Hunter H.M., Glover J.S. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem. J. 1963, 89:114-123.
7. Constantinides P.P., Welzel G., Ellens H., Smith P.L., Sturgis S., Yiv S.H., Owen A.B. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation. Pharm. Res. 1996, 13:210-215.
8. 2 production. J. Pham. Exp. Ther. 1997, 283:1069-1085.
9. Russell-Jones G.J., Lee S., McMenigall K., Luke M., Himes R. Topical Delivery of Proteins Using Microemulsions. Proceedings of 34th International Symposium on Controlled Release of Bioactive Materials 2007.
10. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-227.
11. Higgins J.C., Eady R.A. Human dermal microvasculature: I. Its segmental differentiation. Light and electron microscopic study. Br. J. Dermatol. 1981, 104:117-129.
12. Plante G.E., Chakir M., Ettaouil K., Lehoux S., Sirois P. Consequences of alteration in capillary permeability. Can. J. Physiol. Pharmacol. 1996, 74:824-833.
13. Leu A.J., Husmann M.J.W., Held T., Frisullo R., Hoffmann U., Franzeck U.K. Measurement of the lymphatic clearance of the human skin using a fluorescent tracer. J. Vasc. Res. 2001, 38:423-431.
14. Puri N., Weyand E.H., Abdel-Rahman S.M., Sinko P.J. An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems. Vaccine 2000, 18:2600-2612.
15. G.J. Russell-Jones, M. Luke and R. Himes, Transdermal delivery of pharmaceutical agents. USP 2007/0243132 (2007).